Chief Business Officer
CurrentGryphon Bio is an expert proteomics company that identifies, characterizes, develops high sensitivity assays for, and clinically validates blood tests for brain biomarkers. Gryphon is in clinical collaboration with DoD and leading worldwide consortia in traumatic brain injury (TBI) and neurodegenerative diseases. The company plans to launch commercial.